keyword
MENU ▼
Read by QxMD icon Read
search

Rivaroksaban

keyword
https://www.readbyqxmd.com/read/27883351/-rivaroxaban-resistant-right-ventricular-thrombus-successfully-treated-with-vitamin-k-antagonist-in-a-patient-with-dilated-cardiomyopathy
#1
Waldemar Elikowski, Małgorzata Małek-Elikowska, Marek Słomczyński, Teresa Ganowicz-Kaatz, Andrzej Bolewski, Paweł Skrzywanek
: Rivaroxaban, a selective inhibitor of active factor X belongs to the group of direct-acting oral anticoagulants (DOAC), more and more often replacing vitamin K antagonists (VKA) in venous thromboembolic disease and nonvalvular atrial fibrillation. Attempts are also being made to use DOAC to treat locally formed intracardiac thrombi, mainly in the left atrium and its appendage, in atrial fibrillation and in heart failure. Rarely diagnosed local right ventricular thrombus (RVT) may be a complication of dilated cardiomyopathy (DCM)...
November 25, 2016: Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego
https://www.readbyqxmd.com/read/27755410/the-rate-of-epistaxis-incidence-in-new-generation-anticoagulants-and-perioperative-approach-in-otorhinolaryngological-practices
#2
Ozan Gökdoğan, Ilker Akyildiz, Begum Yetis Sayin, Sercan Okutucu, Ali Cevat Tanalp, Necmi Arslan
Nose bleeding is a common situation seen in otorhinolaryngological practices. One of the greatest risk factors in nose bleeding is the use of anticoagulant medicine. With the medicine developed in recent years, the risk of nose bleeding due to the frequent use of anticoagulant and antiagregant is gradually increasing.The purpose of this study is to determine the effects of especially new-generation anticoagulants on nose bleeding. In addition, the use and complications of new-generation anticoagulants and antiagregants have been compiled in light of information obtained from the literature...
October 14, 2016: Journal of Craniofacial Surgery
https://www.readbyqxmd.com/read/23863207/-comparison-of-the-therapeutic-effect-of-the-warfarin-and-rivaroksaban-among-the-patients-with-not-valuate-fibrillation-of-atrium
#3
COMPARATIVE STUDY
V I Tseluĭko, N A Opolonskaia, Z S Vashakidze
In this article the results of comparative assessment of the efficiency of the Rivaroksaban and Varfarine for prevention of stroke and systemic embolic complications in middle and high- stroke risk patients with nonvalvular artial fibrillation are presented. Detailed analysis of some risk factors is conducted according to scales: CHADS2, CHA2DS2-VASc and HAS-BLED. The frequency of development of endpoints is defined (stroke, TIA, system embolism, cardiac infarction or death due to cardiovascular reasons, or combination of outcomes) according to initial risk and anticoagulant treatment...
June 2013: Georgian Medical News
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"